Relevant bibliographies by topics / Platinum compounds

Academic literature on the topic 'Platinum compounds'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Platinum compounds.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Platinum compounds"

1

Steggerda, J. J. "Platinum-Gold Cluster Compounds." Comments on Inorganic Chemistry 11, no. 2-3 (December 1990): 113–29. http://dx.doi.org/10.1080/02603599008035821.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hartmann, Jörg Thomas, and Hans-Peter Lipp. "Toxicity of platinum compounds." Expert Opinion on Pharmacotherapy 4, no. 6 (June 2003): 889–901. http://dx.doi.org/10.1517/14656566.4.6.889.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Martínez-Salvador, Sonia, Juan Forniés, Antonio Martín, and Babil Menjón. "Highly Trifluoromethylated Platinum Compounds." Chemistry - A European Journal 17, no. 29 (June 3, 2011): 8085–97. http://dx.doi.org/10.1002/chem.201100626.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kasyanenko, Nina, Zhang Qiushi, Vladimir Bakulev, Petr Sokolov, and Konstantin Yakovlev. "DNA Conformational Changes Induced by Its Interaction with Binuclear Platinum Complexes in Solution Indicate the Molecular Mechanism of Platinum Binding." Polymers 14, no. 10 (May 17, 2022): 2044. http://dx.doi.org/10.3390/polym14102044.

Full text
Abstract:
Platinum anticancer drugs inhibit the division of cancer cells through a DNA binding mechanism. The bimetallic platinum compounds have a possibility for blocking DNA replication via the cross-linking of DNA functional groups at different distances. Many compounds with metals of the platinum group have been tested for possible antitumor activity. The main target of their biological action is a DNA molecule. A combined approach to the study of the interaction of DNA with biologically active compounds of this type is proposed. The capabilities of various methods (hydrodynamic, spectral, microscopy) in obtaining information on the type of binding of coordination compounds to DNA are compared. The analysis of DNA binding with platinum binuclear compounds containing pyrazine, tetrazole, 5- methyltetrazole, 3-propanediamine as bridging ligands in a solution was carried out with the methods of circular dichroism (CD), luminescent spectroscopy (LS), low gradient viscometry (LGV), flow birefringence (FB) and atomic force microscopy (AFM). The competitive binding of different platinum compounds to DNA and the analysis of platinum attachment to DNA after protonation of its nitrogen bases simply indicates the involvement of N7 guanine in binding. Fluorescent dye DAPI was also used to recognize the location of platinum compounds in DNA grooves. DNA conformational changes recorded by variations in persistent length, polyelectrolyte swelling, DNA secondary structure, and its stability clarify the molecular mechanism of the biological activity of platinum compounds.
APA, Harvard, Vancouver, ISO, and other styles
5

Crespo, Margarita. "Fluorine in Cyclometalated Platinum Compounds." Organometallics 31, no. 4 (October 20, 2011): 1216–34. http://dx.doi.org/10.1021/om200835g.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mingos, D. Michael P., and Robert W. M. Wardle. "Homonuclear cluster compounds of platinum." Transition Metal Chemistry 10, no. 12 (1985): 441–59. http://dx.doi.org/10.1007/bf00620708.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

MELNIK, M., and C. HOLLOWAY. "Stereochemistry of platinum coordination compounds." Coordination Chemistry Reviews 250, no. 17-18 (September 2006): 2261–70. http://dx.doi.org/10.1016/j.ccr.2006.02.020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

M.J.C. "Platinum Compounds in Cancer Chemotherapy." Platinum Metals Review 29, no. 2 (April 1, 1985): 72. http://dx.doi.org/10.1595/003214085x2927272.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Aris, Sheena M., and Nicholas P. Farrell. "Towards Antitumor Activetrans-Platinum Compounds." European Journal of Inorganic Chemistry 2009, no. 10 (April 2009): 1293–302. http://dx.doi.org/10.1002/ejic.200801118.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Romano, Alberto, Michele Antonio Capozza, Stefano Mastrangelo, Palma Maurizi, Silvia Triarico, Rolando Rolesi, Giorgio Attinà, Anna Rita Fetoni, and Antonio Ruggiero. "Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer." Cancers 12, no. 5 (May 17, 2020): 1266. http://dx.doi.org/10.3390/cancers12051266.

Full text
Abstract:
Platinum compounds are a group of chemotherapeutic agents included in many pediatric and adult oncologic treatment protocols. The main platinum compounds are cisplatin, carboplatin, and oxaliplatin. Their use in clinical practice has greatly improved long-term survival of pediatric patients, but they also cause some toxic effects: ototoxicity, myelosuppression, nephrotoxicity, and neurotoxicity. Hearing damage is one of the main toxic effects of platinum compounds, and it derives from the degeneration of hair cells of the ear, which, not having self-renewal capacity, cannot reconstitute themselves. Hearing loss from platinum exposure is typically bilateral, sensorineural, and permanent, and it is caused by the same mechanisms with which platinum acts on neoplastic cells. According to available data from the literature, the optimal timing for the audiological test during and after treatment with platinum compounds is not well defined. Moreover, no substances capable of preventing the onset of hearing loss have been identified.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Platinum compounds"

1

Lee, Daniel E. "Development of Non-Traditional Platinum Anticancer Agents: trans-Platinum Planar Amine Compounds and Polynuclear Platinum Compounds." VCU Scholars Compass, 2015. http://scholarscompass.vcu.edu/etd/3809.

Full text
Abstract:
Development of Non-Traditional Platinum Anticancer Agents: trans-Platinum Planar Amine Compounds and Polynuclear Platinum Compounds By Daniel E. Lee, Ph.D. A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Virginia Commonwealth University. Virginia Commonwealth University, 2015 Major Director: Nicholas P Farrell, Ph.D., Professor, Department of Chemistry Platinum anticancer compounds with cis geometry, similar to cisplatin, have been explored to circumvent the cisplatin resistance; however, they were not considered broadly active in cisplatin cells due to exhibiting similar or same cell death mechanism as cisplatin. Platinum compounds with trans geometry were less studied due to transplatin being clinically inactive; but with few structural modifications, they resulted in unaffected cytotoxic activities in cisplatin resistant cells with structural modification by exhibiting different modes of DNA binding. This research focused on further exploring and establishing structure-activity relationship of two promising non-classical series of platinum compounds with trans-geometry: trans-platinum planar amine (TPA) compounds and noncovalently binding polynuclear platinum compounds (PPC-NC). During this research, further optimizations of the reactivity of TPA compounds were accomplished by modifying the leaving carboxylate groups. The effects of modified reactivity were probed by a systematic combination of chemical and biophysical assays, followed by evaluating their biological effects in cells. To establish the structural-activity relationship of PPC-NCs, Mono-, Di-, Tri-, and Tetraplatin NC with charge of 4+, 6+, 8+, and 10+ were synthesized and evaluated by utilizing biophysical and biological assays. Lastly, a new class of polynuclear platinum compounds, Hybrid-PPCs, were synthesized and evaluated to overcome the pharmacokinetic problems of BBR3464, phase II clinical trial anticancer drug developed previously in our laboratory.
APA, Harvard, Vancouver, ISO, and other styles
2

Wang, Hongli. "A study of the structural, microstructural and magnetic properties of iron-platinum and cobalt-platinum type nanoparticles." Access to citation, abstract and download form provided by ProQuest Information and Learning Company; downloadable PDF file, 200 p, 2007. http://proquest.umi.com/pqdweb?did=1354136761&sid=4&Fmt=2&clientId=8331&RQT=309&VName=PQD.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sherman, D. J. "Studies on some platinum metal compounds." Thesis, University of Oxford, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.382671.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Haggitt, Jane Louise. "Cluster compounds of platinum and gold." Thesis, University of Oxford, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.334859.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Burrows, Andrew David. "Cluster compounds of palladium and platinum." Thesis, University of Oxford, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.302903.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tooze, R. P. "Organometallic compounds of platinum group metals." Thesis, Imperial College London, 1985. http://hdl.handle.net/10044/1/37880.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Davis, John Christopher. "A Speciation study of the chloro-hydroxo complexes of Pt(II)." Thesis, Nelson Mandela Metropolitan University, 2009. http://hdl.handle.net/10948/1213.

Full text
Abstract:
In this study a method was developed to identify and quantify platinum(II) complexes of the type [PtCl4-n(OH)n]2- and [PtCl4-n(H2O)n]2-n. Separation of the various species was achieved with the aid of a hyphenated reversed phase HPLC-ICP-MS technique coupled with an ion-pairing reagent, HMHDCl2. The adsorption of HMHD2+ onto a C-18 column was investigated by generating a series of breakthrough curves. It was found that the selectivity for high charge density anions originates from its low surface coverage relative to TBA+, which on the other hand could not separate Pt(II) complexes. The peaks in the chromatographic traces were assigned by following the stepwise ligand substitution of [PtCl4]2- in hydroxide medium with UV/Vis spectrophotometry and HPLC-ICP-MS simultaneously. A computer program was written by the author to analyse chromatographic data by deconvoluting the chromatogram into its individual components and calculating the mole fraction of each component. The validity of the consecutive pseudo-first order model was validated by constructing 3D Mauser diagrams with the raw spectrophotometric data (A1 vs A2 vs A3). Additional software was used to simulate the raw spectrophotometric data and processed chromatographic data. The pseudo-first order rate constants obtained in both cases were in agreement with each other. Hence, peaks were assigned to [PtCl4]2-, [PtCl3(OH)]2-, [PtCl2(OH)2]2-, [PtCl3(H2O)]-. The molar extinction coefficient spectra of [PtCl3(OH)]2- and [PtCl2(OH)2]2- were obtained by simulating the spectrophotometric data at wavelengths from 280 to 450 nm. The reaction of [PtCl4]2- with sodium hydroxide was investigated with UV/Vis spectrophotometry at 25 °C. A rate constant consisting of a first and second order term was obtained. The first order term agreed with what has been reported in the literature for aquation of [PtCl4]2- at 25 degrees C. The influence of temperature was established by conducting the experiment at different temperatures. It was found that the reaction proceeds essentially via aquation at elevated temperatures.
APA, Harvard, Vancouver, ISO, and other styles
8

Hoogervorst, Wilhelmus Johannes. "Isophthalaldimine compounds of palladium, platinum and rhodium." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2003. http://dare.uva.nl/document/69284.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ezomo, O. J. "Studies on palladium and platinum cluster compounds." Thesis, University of Oxford, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.234990.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jones, Jane Helen. "New heteroborane cluster compounds of platinum metals." Thesis, University of Leeds, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.303439.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Platinum compounds"

1

Howell, Stephen B., ed. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4899-0738-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bonetti, Andrea, Roberto Leone, Franco M. Muggia, and Stephen B. Howell, eds. Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-459-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nicolini, Marino, ed. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-1717-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy (6th 1991 San Diego, Calif.). Platinum and other metal coordination compounds in cancer chemotherapy. New York: Plenum Press, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Canty, Allan J. Higher Oxidation State Organopalladium and Platinum Chemistry. Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pinedo, H. M., and J. H. Schornagel, eds. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4899-0218-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

M, Pinedo H., and Schornagel J. H, eds. Platinum and other metal coordination compounds in cancer chemotherapy 2. New York: Plenum Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

International Symposium on Platinum Coodination Compounds in Cancer Chemotherapy (10th 2007 Verona, Italy). Platinum and other heavy metal compounds in cancer chemotherapy: Molecular mechanisms and clinical applications. New York: Humana Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

C, Bruneau, and Dixneuf P. H, eds. Ruthenium catalysts and fine chemistry. Berlin: Springer, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Laboratory, Occupational Medicine and Hygiene. Platinum metal and soluble inorganic compounds of platinum in air: Laboratory method using carbon furnace atomic absorption spectrometry. [Bootle]: Health and Safety Executive, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Platinum compounds"

1

Litterst, Charles L., and Eddie Reed. "Platinum Compounds." In Cancer Management in Man, 85–97. Dordrecht: Springer Netherlands, 1989. http://dx.doi.org/10.1007/978-94-009-1095-9_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bernfeld, G. J., A. J. Bird, R. I. Edwards, Hartmut Köpf, Petra Köpf-Maier, Christoph J. Raub, W. A. M. te Riele, Franz Simon, and Walter Westwood. "Medical Use of Cytostatic Platinum Compounds." In Pt Platinum, 318–38. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-662-10278-7_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Macintyre, J. E. "Pt Platinum." In Dictionary of Organometallic Compounds, 273–82. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4615-6847-6_40.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

MacIntyre, Jane E. "Pt Platinum." In Dictionary of Organometallic Compounds, 186–94. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4899-6848-7_43.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Macintyre, J. E., F. M. Daniel, D. J. Cardin, S. A. Cotton, R. J. Cross, A. G. Davies, R. S. Edmundson, et al. "Pt Platinum." In Dictionary of Organometallic Compounds, 152–60. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4757-4966-3_44.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bernfeld, G. J., A. J. Bird, R. I. Edwards, Hartmut Köpf, Petra Köpf-Maier, Christoph J. Raub, W. A. M. te Riele, Franz Simon, and Walter Westwood. "Platinum-Group Metals, Alloys and Compounds in Catalysis." In Pt Platinum, 92–317. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-662-10278-7_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nagy, Zoltán. "Pt—Platinum." In Electrochemical Synthesis of Inorganic Compounds, 384. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4899-0545-1_51.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Baer, Lea, Franco M. Muggia, and Silvia C. Formenti. "Platinum Compounds and Radiation." In Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy, 211–23. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-459-3_26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pieper, Thomas, Karl Borsky, and Bernhard K. Keppler. "Non-Platinum Antitumor Compounds." In Metallopharmaceuticals I, 171–99. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-662-03815-4_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kelland, Lloyd R. "Platinum anticancer drugs." In Metal Compounds in Cancer Therapy, 32–45. Dordrecht: Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-011-1252-9_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Platinum compounds"

1

Feng-Yi Yang and Shih-Cheng Horng. "Chemotherapy of glioblastoma by targeted liposomal platinum compounds with focused ultrasound." In 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2013. http://dx.doi.org/10.1109/embc.2013.6610991.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rúa-Sueiro, Marcos, Paula Munin-Cruz, Francisco Reigosa, José M. Vila, M. Teresa Pereira, and Juan M. Ortigueira. "Synthesis of mono- and dinuclear cyclometallated compounds with palladium and platinum." In The 24th International Electronic Conference on Synthetic Organic Chemistry. Basel, Switzerland: MDPI, 2020. http://dx.doi.org/10.3390/ecsoc-24-08299.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tamanna and Gurmeet Kaur. "A review on medicinal applications of Vanadium, Platinum, and Ruthenium based-coordination compounds." In 14TH INTERNATIONAL CONFERENCE ON MATERIALS PROCESSING AND CHARACTERIZATION 2023. AIP Publishing, 2024. http://dx.doi.org/10.1063/5.0193561.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jeremić, Svetlana, Milan Dekić, Violeta Jakovljević, Enisa Selimović, and Amina Gusinac. "Inhibitory potential of barbarin and its platinum(II) complex towards PBP1a protein." In 2nd International Conference on Chemo and Bioinformatics. Institute for Information Technologies, University of Kragujevac, 2023. http://dx.doi.org/10.46793/iccbi23.617j.

Full text
Abstract:
Some natural compounds and their metal complexes have been proven to show a significant ability to inhibit some proteins. By using in silico techniques, we examined how effectively the biologically active natural compound barbarin and its Pt(II) complex inhibit penicillin-binding protein 1A (PBP1a). DFT calculations are used to optimize the geometry of ligands. Molecular docking analysis is used to evaluate the binding positions, inhibition constants, and binding energies of complexes formed between ligands and the PBP1a protein. The inhibitory potency of the investigated ligands is compared to that of lactivicin, an antibiotic that is already utilized in the treatment of Gram-negative and Gram-positive bacteria. Docking research revealed that the Pt(II)-barbarin complex inhibits the PBP1a protein significantly more effectively than lactivicin, while barbarin has a similar inhibitory activity as lactivicin. The theoretically obtained results were also confirmed experimentally, by treating Escherichia coli, Staphylococcus aureus, and Bacillus subtilis bacteria with a solution of barbarin. Based on the obtained results, barbarin and Pt(II)-barbarin complex can be considered as candidates for further investigations with the aim of their potential application in Streptococcus pneumoniae therapy.
APA, Harvard, Vancouver, ISO, and other styles
5

Mohell, Nina, Jessica Alfredsson, Åsa Fransson, Vladimir Bykov, Mikael von Euler, Klas Wiman, and Ulf Björklund. "Abstract 1801: APR-246, a clinical-stage mutant p53-reactivating compound, resensitizes ovarian cancer cells to platinum compounds and doxorubicin." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-1801.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Stojković, Danijela Lj, Verica V. Jevtić, Đorđe S. Petrović, Sandra S. Jovičić Milić, Nenad L. Vuković, Milena D. Vukić, and Bojan Stojanović. "SYNTHESIS AND CHARACTERIZATION OF PLATINUM(II/IV) COMPLEXES WITH 2-AMINO-5-METHYL-4-PHENYLTHIAZOLE." In 1st INTERNATIONAL Conference on Chemo and BioInformatics. Institute for Information Technologies, University of Kragujevac, 2021. http://dx.doi.org/10.46793/iccbi21.339s.

Full text
Abstract:
This paper examines the synthesis of two new complexes of platinum(II/IV) ion, general formula [PtL2]Cl2 and [PtL2]Cl4, where L is 2-amino-5-methyl-4-phenylthiazole. The structures of the above mentioned compounds were determined by elemental microanalysis, infrared, 1H and 13C NMR spectroscopy.
APA, Harvard, Vancouver, ISO, and other styles
7

Antonichen, Magno R., Sergio R. de Lazaro, Luis H. S. Lacerda, Flavia Marszaukowski, Ivelise D. L. Guimarães, Karen Wohnrath, and Rene Boere. "DFT simulations for the [6-p-cymene)RuCl2(apy)] complex." In VIII Simpósio de Estrutura Eletrônica e Dinâmica Molecular. Universidade de Brasília, 2020. http://dx.doi.org/10.21826/viiiseedmol202097.

Full text
Abstract:
Anticarcinogen compounds are extensively investigated in current days. Among the potential alternatives to develop effective drugs for this purpose, stands out the ruthenium (II) complex presents satisfactory anti-tumor activity. In particular, this kind of compounds has been investigated as a possible substitute for Platinum-based drugs. However, Ru (II) complexes need more investigation to understand the ligands' effect on biological environments, such as cytotoxicity, metabolism, accumulation on tumor issues, and others. Therefore, in this work, a robust DFT/B3LYP theoretical investigation was performed using GAUSSIAN09 in order to investigate the effects of the +1 and -1 charges on structural and electronic properties of the (6-p-cymene)Ru(II)Cl2(apy) complex. The structure evaluation indicates that +1 charged complex has a slight reduction on the Ru – cymene, Ru – Cl and Ru – apy bond lengths regarding the neutral complex. On the other hand, -1 charged complex shows bond lengths very similar to the neutral compound, except by a very large distance between Ru and one Cl atom, indicating that such atoms were expelled.
APA, Harvard, Vancouver, ISO, and other styles
8

Petrović, Biljana. "TRANSITION METAL ION COMPLEXES AS POTENTIAL ANTITUMOR AGENTS." In 1st INTERNATIONAL Conference on Chemo and BioInformatics. Institute for Information Technologies, University of Kragujevac,, 2021. http://dx.doi.org/10.46793/iccbi21.009p.

Full text
Abstract:
Discovery of the antitumor activity of platinum complex, cisplatin, cis-Pt(NH3)2Cl2, and later carboplatin and oxaliplatin, led to the intensive investigation of the potential antitumor activity of the huge number of platinum complexes. Furthermore, it is well-known that platinum complexes express toxicity, numerous side effects and resistance, so the scientists make a lot of efforts to synthetize, beside Pt(II) and Pt(IV), other non-platinum compounds with potential antitumor activity, such as Pd(II), Ru(II/III) and Au(III) complexes. The goal of this study is to summarize the results of the investigation of the interactions between some mononuclear, homo- and hetero-polynuclear Pt(II), Pd(II), Ru(II/III) and Au(III) complexes with different sulfur- and nitrogen-donor biologically relevant nucleophiles. Among mononuclear complexes, the compounds with aromatic terpy (tepyridine) or bpma (bis-(2- pyridylmethyl)amine) and aliphatic dien (diethylentriamine) nitrogen-containing inert ligands were studied. Different homo- and hetero-polynuclear complexes with pz (pyrazine) or 4,4’-bipy (4,4’- bipyridine) as bridging and mostly en (ethylenediamine), bipy (2,2’-bipyridine) and dach (trans-1,2- diaminocyclohexane) as inert ligands were studied as well. The research was focused on the connection between the structure and the mechanisms of interactions with different biomolecules, such as L- cysteine (L-Cys), L-methionine (L-Met), tripeptide glutathione (GSH), guanosine-5’-monophosphate (5’-GMP), DNA and bovine serum albumin (BSA). Some of these complexes were selected for in vitro studies of the cytotoxicity on different tumor cell lines. Observed results contribute a lot as a guidance for the future design and determination of the structure-activity relationship (SAR) of different transition metal ion complexes.
APA, Harvard, Vancouver, ISO, and other styles
9

Bur, Christian, Mike Andersson, Anita Lloyd Spetz, Nikolai Helwig, and Andreas Schutze. "Detecting Volatile Organic Compounds in the ppb range with platinum-gate SiC-Field Effect Transistors." In 2013 IEEE Sensors. IEEE, 2013. http://dx.doi.org/10.1109/icsens.2013.6688279.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Borisov, R. V., O. V. Belousov, N. V. Belousova, and A. A. Akimenko. "DISSOLUTION OF PLATINUM GROUP METALS IN AN AUTOCLAVE." In XVI INTERNATIONAL CONFERENCE "METALLURGY OF NON-FERROUS, RARE AND NOBLE METALS" named after corresponding member of the RAS Gennady Leonidovich PASHKOVA. Krasnoyarsk Science and Technology City Hall, 2023. http://dx.doi.org/10.47813/sfu.mnfrpm.2023.339-346.

Full text
Abstract:
Platinum metals (PGMs) find wide practical application in high-tech areas and allow solving a number of economic and environmental problems. Under normal conditions, platinum metals are thermodynamically stable and resistant to the action of mineral acids and alkalis. On the other hand, a feature of PGMs and their compounds is the kinetic inhibition of processes involving them. The constant growth in the consumption of precious metals requires solving the problems of their highly efficient extraction from primary ores and concentrates, secondary raw materials, which are mainly represented by spent catalysts and electronic scrap. Processing is carried out using pyro- and hydrometallurgical methods. Modern hydrometallurgical technologies for the processing of precious metals are most preferable due to their greater environmental friendliness compared to pyrometallurgical processes. The most efficient transfer of platinum group metals into solution can be carried out at elevated temperatures and pressures, which makes it possible to remove kinetic difficulties. To do this, autoclaves are used, the use of which does not lead to losses and contamination with impurities of valuable metals, makes it possible to intensify the processes of dissolution and reduce the environmental burden on the environment. Unfortunately, despite the rapid development of autoclave technologies, there are few studies on the dissolution of pure metals under autoclave conditions. At the same time, the establishment of the mechanism and factors influencing the process of dissolution of metals will make it possible to develop and optimize existing schemes for processing platinum-containing raw materials.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Platinum compounds"

1

Olsen. PR-179-10203-R01 Characterization of Oxidation Catalyst Performance - VOCs and Temperature Variation. Chantilly, Virginia: Pipeline Research Council International, Inc. (PRCI), June 2012. http://dx.doi.org/10.55274/r0010753.

Full text
Abstract:
Oxidation catalysts are typically specified to reduce carbon monoxide (CO), Hazardous Air Pollutants (HAPs) and/or Volatile Organic Compounds (VOCs) from lean-burn engines. The application of catalysts to HAPs and VOC destruction is more recent, so greater effort has been placed on optimizing for CO oxidation than HAPs or VOC oxidation. In general, the catalysts consist of a porous, high surface area -alumina carrier material on a ceramic (typically cordierite) or stainless steel substrate. Although the alumina has some effectiveness in oxidation at high temperature, its primary role here is to provide a high surface area support for a well dispersed layer of platinum (Pt) and/or palladium (Pd) which provides numerous catalytic sites for oxidation activity. This work extends the current knowledge-base for application of oxidation catalysts in three areas: (1) species specific removal efficiencies, (2) temperature dependence, and (3) space velocity.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Platinum compounds' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography